As of the latest Form 4 filed Apr 24, 2026.
What Vor Biopharma Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 16 most recent filings for VOR.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | 2026-04-22 | RA CAPITAL MANAGEMENT, L.P. Director | SSale | −165K | $15.77 | $2.60M | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-20 | RA CAPITAL MANAGEMENT, L.P. Director | SSale | −172K | $15.77 | $2.71M | No | Form 4 ↗ |
| 2026-04-21 | 2026-04-17 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −458K | $16.28 | $7.46M | No | Form 4 ↗ |
| 2026-04-15 | 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. Director | SSale | −53.6K | $16.01 | $859K | No | Form 4 ↗ |
| 2026-04-15 | 2026-04-14 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −154K | $15.97 | $2.46M | No | Form 4 ↗ |
| 2026-04-15 | 2026-04-13 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −531K | $16.15 | $8.57M | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-10 | RA CAPITAL MANAGEMENT, L.P. Director | SSale | −828.00 | $15.75 | $13.0K | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-09 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −135K | $16.59 | $2.24M | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −131K | $16.91 | $2.21M | No | Form 4 ↗ |
| 2026-04-10 | 2026-04-08 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −353K | $16.32 | $5.76M | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-06 | RA CAPITAL MANAGEMENT, L.P. Director | SSale | −6.78K | $18.50 | $125K | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-06 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −44.7K | $17.31 | $774K | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-06 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −538K | $16.51 | $8.88M | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −1.52K | $19.06 | $29.1K | No | Form 4 ↗ |
| 2026-04-06 | 2026-04-02 | RA CAPITAL MANAGEMENT, L.P., Director | SSale | −258K | $18.23 | $4.71M | No | Form 4 ↗ |
| 2025-12-19 | 2025-12-18 | RA CAPITAL MANAGEMENT, L.P. Director | AAward | −4.63M | $10.81 | $50.0M | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also VOR’s full analysis or the market-wide insider trading feed. The tabs above jump to VOR’s other SEC data.
Source: SEC Form 4 filings for VOR, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.